Skip to main content

Table 7 Multiple regression analyses (stepwise); predicting lnCRP levels (lowest value obtained from 2 or 3 blood withdrawal days) entering body mass index (BMI), age, smoking, alcohol use and the insulin resistance parameters (insulin, total cholesterol, HDL-C, LDL-C triglycerides, t-PA antigen, t-PA activity, PAI-1 antigen) into the regression. Results are given for men, no-oral contraceptives (OC) using women, and oral contraceptives using women, separately.

From: Diagnostic strategies for C-reactive protein

Men

Variable

Ī² coefficient

p-value

R2

Constant

-2.697

0.001

Ā 

Fibrinogen#

1.182

0.000

0.325

BMI#

2.306

0.000

0.390

Smoking

0.106

0.000

0.461

Age#

-0.975

0.004

0.478

t-PA antigen#

-0.141

0.004

0.487

t-PA activity#

-0.064

0.016

0.498

LDL-C

0.044

0.031

0.506

No OC-using women

Variable

Ī² coefficient

p-value

R2

Constant

-3.613

0.000

Ā 

BMI#

1.957

0.000

0.344

Fibrinogen#

0.919

0.000

0.452

PAI-1 antigen#

0.108

0.006

0.473

Insulin#

-0.136

0.035

0.491

OC-using women

Variable

Ī² coefficient

p-value

R2

Constant

-4.246

0.000

Ā 

Fibrinogen#

1.375

0.000

0.327

BMI#

2.192

0.000

0.411

HDL-C

0.202

0.011

0.445

  1. (Note: BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; lnCRP = natural logarithmic transformed C-reactive protein; PAI-1 = plasminogen activator inhibitor-1;t-PA= tissue-type plasminogen activator; # = transformed to normal distribution before entered into the analyses).